Optimal medical therapy with or without percutaneous coronary intervention to reduce ischemic burden: results from the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial nuclear substudy.

LJ, Shaw; DS, Berman; DJ, Maron; GB, Mancini; SW, Hayes; PM, Hartigan; WS, Weintraub; RA, O'Rourke; M, Dada; JA, Spertus; BR, Chaitman; J, Friedman; P, Slomka; GV, Heller; G, Germano; G, Gosselin; P, Berger; WJ, Kostuk; RG, Schwartz; M, Knudtson; E, Veledar; ER, Bates; B, McCallister; KK, Teo; WE, Boden

doi:10.1161/circulationaha.107.743963

Public

Optimal medical therapy with or without percutaneous coronary intervention to reduce ischemic burden: results from the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial nuclear substudy.

Shared by NobleBlocks on Feb 11, 2008 • 12:00 AM UTC

Authors:

Shaw LJ

Berman DS

Maron DJ

Abstract

Background Extent and severity of myocardial ischemia are determinants of risk for patients with coronary artery disease, and ischemia reduction is an important therapeutic goal. The Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) nuclear substudy compared the ...

Discussions